No patient who's been treated with a chemotherapy product at the centre of a contamination scare has shown unexpected side effects.
Thats according to the Health Products Regulatory Authority which says approximately 100 patients were treated with the product.
13 public and 6 private hospitals were alerted about the potential problem - after the manufacturer's "test product" showed signs of contamination.
John Lynch is Director of Compliance at the HPRA:
